Home › Compare › ENZC vs NOBL

ENZC vs NOBL: Dividend Comparison 2026

ENZC yields 500000.00% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENZC wins by $4.663521010693878e+33M in total portfolio value
10 years
ENZC
ENZC
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full ENZC calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — ENZC vs NOBL

📍 ENZC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodENZCNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ENZC + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ENZC pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENZC
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, ENZC beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENZC + NOBL for your $10,000?

ENZC: 50%NOBL: 50%
100% NOBL50/50100% ENZC
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENZC buys
0
NOBL buys
0
No recent congressional trades found for ENZC or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricENZCNOBL
Forward yield500000.00% ✓2.17%
Annual dividend / share$2.00$2.27 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.663521010693878e+33M$22.9K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$249.78
Total dividends collected$4.6634009849658873e+33M ✓$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ENZC vs NOBL ($10,000, DRIP)

YearENZC PortfolioENZC Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$50,010,700$50,000,000.00$10,917$217.08+$50.00M → ENZC
2$233,748,371,262$233,694,859,813.08$11,903$221.48+$233748.36M → ENZC
3$1,021,074,511,412,696$1,020,824,400,655,446.10$12,962$225.68+$1021074511.40M → ENZC
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$14,099$229.68+$4168597328794.94M → ENZC
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$15,319$233.49+$15905475114600664.00M → ENZC
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$16,628$237.10+$56718938532531060736.00M → ENZC
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$18,033$240.53+$1.8903180743562385e+23M → ENZC
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$19,539$243.78+$5.8879981047651824e+26M → ENZC
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$21,154$246.86+$1.7140642681147225e+30M → ENZC
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$22,884$249.78+$4.663521010693878e+33M → ENZC

ENZC vs NOBL: Complete Analysis 2026

ENZC — Stock

Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.

Full ENZC Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this ENZC vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENZC vs SCHDENZC vs JEPIENZC vs OENZC vs KOENZC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.